Le Mans, France

Chrystelle Gilet


Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chrystelle Gilet

Introduction

Chrystelle Gilet is a notable inventor based in Le Mans, France. She has made significant contributions to the field of chemistry, particularly in the development of new processes for the synthesis of important pharmaceutical compounds. With a total of 2 patents, her work has the potential to impact chemotherapy treatments.

Latest Patents

Gilet's latest patents focus on cephalotaxane derivatives and the processes for their preparation. The first patent describes a new general process for the asymmetric hemisynthesis of harringtonines and their analogs, which are alkaloids used in chemotherapy. This innovative process involves the direct esterification of a natural cephalotaxine with an acylating compound, which is composed of a side chain precursor whose backbone and functionalization are entirely preformed. This method represents a significant advancement in the synthesis of these vital compounds.

Career Highlights

Throughout her career, Chrystelle Gilet has worked with various companies, including Stragen Pharma SA and Oncopharm Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to important projects in the pharmaceutical industry.

Collaborations

Gilet has collaborated with several professionals in her field, including Jean-Pierre Robin and Julie Blanchard. These collaborations have fostered a productive environment for innovation and development in her research endeavors.

Conclusion

Chrystelle Gilet's work in the field of chemistry, particularly her patents related to cephalotaxane derivatives, showcases her innovative spirit and dedication to improving chemotherapy treatments. Her contributions are valuable to the ongoing advancements in pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…